GlassScriptPhysician profile
Surajan Panday
NPI 1346968344
$3,190.66
in general payments reported to CMS, 2019-2025
16 companies · $1,009 in 2025
The $1,009 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,151 · 2024: $1,031 · 2025: $1,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,190.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,305.80 | 2023-2025 | Apretude, Cabenuva, Dovato |
| Gilead Sciences, INC. | $965.22 | 2023-2025 | Descovy, Biktarvy |
| Abbvie INC. | $199.21 | 2023-2025 | |
| Amgen INC. | $106.79 | 2023-2025 | Repatha, Otezla, Otezla |
| Novo Nordisk INC | $96.64 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $93.72 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Organon LLC | $80.77 | 2023 | Nexplanon |
| Antares Pharma, INC. | $68.34 | 2024-2025 | Xyosted |
| Merck Sharp & Dohme LLC | $68.22 | 2023-2025 | Pifeltro, Delstrigo |
| Astrazeneca Pharmaceuticals LP | $65.76 | 2024-2025 | Farxiga, Airsupra |
| Exact Sciences Corporation | $42.34 | 2025 | The Cologuard Plus Collection Kit |
| Halozyme INC | $35.15 | 2023 | |
| Supernus Pharmaceuticals, INC. | $18.98 | 2025 | Xyosted, Tlando, Qelbree |
| Pfizer INC. | $15.99 | 2024 | |
| Sun Pharmaceutical Industries INC. | $14.36 | 2023 | Absorica Ld, Winlevi |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $13.37 | 2024 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Surajan Panday listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.